198 related articles for article (PubMed ID: 33363566)
1. Epigenetic Variation Analysis Leads to Biomarker Discovery in Gastric Adenocarcinoma.
Zhang Y; Guo D
Front Genet; 2020; 11():551787. PubMed ID: 33363566
[TBL] [Abstract][Full Text] [Related]
2. Fluctuations of epigenetic regulations in human gastric Adenocarcinoma: How does it affect?
Samadani AA; Noroollahi SE; Mansour-Ghanaei F; Rashidy-Pour A; Joukar F; Bandegi AR
Biomed Pharmacother; 2019 Jan; 109():144-156. PubMed ID: 30396071
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of histone modification-associated genes on differential gene expression and prognosis in gastric cancer.
Meng X; Zhao Y; Liu J; Wang L; Dong Z; Zhang T; Gu X; Zheng Z
Exp Ther Med; 2019 Sep; 18(3):2219-2230. PubMed ID: 31452712
[TBL] [Abstract][Full Text] [Related]
4. CD40 DNA hypermethylation in primary gastric tumors; as a novel diagnostic biomarker.
Amini M; Ghorban K; Mokhtarzadeh A; Dadmanesh M; Baradaran B
Life Sci; 2020 Aug; 254():117774. PubMed ID: 32407843
[TBL] [Abstract][Full Text] [Related]
5. Histone Methyltransferases Useful in Gastric Cancer Research.
Reyes DA; Sarría VMS; Salazar-Viedma M; D'Afonseca V
Cancer Inform; 2021; 20():11769351211039862. PubMed ID: 34413625
[TBL] [Abstract][Full Text] [Related]
6. Methylation Patterns of Lys9 and Lys27 on Histone H3 Correlate with Patient Outcome in Gastric Cancer.
Li Y; Guo D; Sun R; Chen P; Qian Q; Fan H
Dig Dis Sci; 2019 Feb; 64(2):439-446. PubMed ID: 30350241
[TBL] [Abstract][Full Text] [Related]
7. Aberrant Epigenetic Modifications of LPHN2 Function as a Potential Cisplatin-Specific Biomarker for Human Gastrointestinal Cancer.
Jeon MS; Song SH; Yun J; Kang JY; Kim HP; Han SW; Kim TY
Cancer Res Treat; 2016 Apr; 48(2):676-86. PubMed ID: 26511811
[TBL] [Abstract][Full Text] [Related]
8. Gastric cancer: An epigenetic view.
Tang SY; Zhou PJ; Meng Y; Zeng FR; Deng GT
World J Gastrointest Oncol; 2022 Jan; 14(1):90-109. PubMed ID: 35116105
[TBL] [Abstract][Full Text] [Related]
9. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic Mechanisms and Events in Gastric Cancer-Emerging Novel Biomarkers.
Puneet ; Kazmi HR; Kumari S; Tiwari S; Khanna A; Narayan G
Pathol Oncol Res; 2018 Oct; 24(4):757-770. PubMed ID: 29552712
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic modulation associated with carcinogenesis and prognosis of human gastric cancer.
Sonohara F; Inokawa Y; Hayashi M; Kodera Y; Nomoto S
Oncol Lett; 2017 May; 13(5):3363-3368. PubMed ID: 28529571
[TBL] [Abstract][Full Text] [Related]
12. GHSR DNA hypermethylation is a new epigenetic biomarker for gastric adenocarcinoma and beyond.
Amini M; Foroughi K; Talebi F; Aghagolzade Haji H; Kamali F; Jandaghi P; Hoheisel JD; Manoochehri M
J Cell Physiol; 2019 Sep; 234(9):15320-15329. PubMed ID: 30677130
[TBL] [Abstract][Full Text] [Related]
13. Early Epigenetic Markers for Precision Medicine.
Dumitrescu RG
Methods Mol Biol; 2018; 1856():3-17. PubMed ID: 30178243
[TBL] [Abstract][Full Text] [Related]
14. Cancer type-specific epigenetic changes: gastric cancer.
Calcagno DQ; de Arruda Cardoso Smith M; Burbano RR
Methods Mol Biol; 2015; 1238():79-101. PubMed ID: 25421656
[TBL] [Abstract][Full Text] [Related]
15. Interaction of ncRNA and Epigenetic Modifications in Gastric Cancer: Focus on Histone Modification.
Yang Q; Chen Y; Guo R; Dai Y; Tang L; Zhao Y; Wu X; Li M; Du F; Shen J; Yi T; Xiao Z; Wen Q
Front Oncol; 2021; 11():822745. PubMed ID: 35155211
[TBL] [Abstract][Full Text] [Related]
16. Histone and DNA Methylation as Epigenetic Regulators of DNA Damage Repair in Gastric Cancer and Emerging Therapeutic Opportunities.
De Marco K; Sanese P; Simone C; Grossi V
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894343
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation of GATA4 expression by histone modification in AFP-producing gastric adenocarcinoma.
Yamamura N; Kishimoto T
Exp Mol Pathol; 2012 Aug; 93(1):35-9. PubMed ID: 22472323
[TBL] [Abstract][Full Text] [Related]
18. Gastric cancer and related epigenetic alterations.
Patel TN; Roy S; Ravi R
Ecancermedicalscience; 2017; 11():714. PubMed ID: 28144288
[TBL] [Abstract][Full Text] [Related]
19. [Gastric carcinoma and chronic gastritis: epigenetic regulation of CDH1 (E-Cadherin), CDKN2A (p16INK4A), PTGS2 (COX-2) and EGFR genes through methylation].
Silva M; Azenha D; Pereira C; Almeida A; Balseiro S; Sampaio AM; Santos P; Carvalho L
Acta Med Port; 2010; 23(1):5-14. PubMed ID: 20353702
[TBL] [Abstract][Full Text] [Related]
20. Identification of functional methylated CpG loci in PD-L1 promoter as the novel epigenetic biomarkers for primary gastric cancer.
Amini M; Hejazi M; Ghorban K; Mokhtarzadeh A; Baradaran B
Gene; 2021 Mar; 772():145376. PubMed ID: 33359128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
